Related Experiment Video
Updated: Nov 12, 2025
08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.5K
Circular RNA circ_ABCB10 in cancer.
Bowen Liu1, Na Zhao1, Yuanshi Zhou1
1Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, No. 246 XueFu Avenue, Harbin 150086, China.
Summary
Circular RNAs (circRNAs) are stable molecules involved in cell processes. Circ_ABCB10 shows elevated expression in various cancers, indicating its potential as a diagnostic marker and therapeutic target.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Circular RNAs (circRNAs) are novel endogenous noncoding RNAs with stable structures and cell-specific expression.
- circRNAs play roles in cell differentiation, proliferation, invasion, and metastasis, linking them to disease, particularly cancer.
- circ_ABCB10, a specific circRNA, is increasingly recognized for its upregulation in multiple tumor types.
Purpose of the Study:
- To review the molecular regulation and mechanisms of circ_ABCB10 in cancer.
- To explore the potential of circ_ABCB10 as a diagnostic molecular marker.
- To investigate circ_ABCB10 as a novel therapeutic target for cancer treatment.
Main Methods:
- Literature review of studies on circ_ABCB10 expression and function in various cancers.
- Analysis of molecular mechanisms underlying circ_ABCB10's role in cancer progression.
- Evaluation of existing data on circ_ABCB10's prognostic value.
Main Results:
- circ_ABCB10 expression is upregulated in esophageal cancer, breast cancer, lung cancer, and glioma.
- circ_ABCB10 is implicated in key cancer processes like cell differentiation, proliferation, invasion, and metastasis.
- Evidence suggests circ_ABCB10 may hold prognostic value in cancer patients.
Conclusions:
- circ_ABCB10 is a significant circRNA with dysregulated expression in multiple cancers.
- circ_ABCB10 warrants further investigation as a potential biomarker for cancer diagnosis and prognosis.
- Targeting circ_ABCB10 may offer a novel therapeutic strategy for cancer treatment.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.7K
01:20The Retinoblastoma Gene
4.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
02:23Abnormal Proliferation
4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
02:53Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
02:38The Ras Gene
6.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.7K
02:39lncRNA - Long Non-coding RNAs
9.3K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K